LoadingLoadingCookies show us what works. Privacy
Cookies show us what works. Privacy
LoadingCookies show us what works. Privacy
28 funds hold it · Insiders net selling
Net selling: insiders sold $3.2M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Nov 2, 2026
Period ending
Sep 30, 2026
Earnings per share
$2.75 expected
Estimates as of Nov 8, 2026
EPS expected
$2.07 to $3.33
Revenue expected
24 analysts
Last 30 days
Split both ways
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Nov 2, 2026 | $3.29est. $2.75 | +19.83%beat | $1.12BSEC filing | +41.2%from $794.9M |
| Jun 30, 2026Reported Jul 30, 2026 | $2.85est. $1.96 | +45.44%beat | $959.0MSEC filing | +39.5%from $687.5M |
| Mar 31, 2026Reported May 5, 2026 | $1.94est. $1.70 | +14.36%beat | $814.5MSEC filing | +42.2%from $572.6M |
| Dec 31, 2025Reported Feb 11, 2026 | $1.88est. $2.30 | -18.13%miss | $805.5MAlpha Vantage | +28.3%from $627.7M |
| Sep 30, 2025Reported Oct 28, 2025 | $2.17est. $2.07 | +4.83%beat | $794.9MSEC filing | +27.8%from $622.1M |
| Jun 30, 2025Reported Jul 30, 2025 | $1.65est. $1.50 | +10.00%beat | $687.5MSEC filing | +16.5%from $590.2M |
| Mar 31, 2025Reported May 5, 2025 | $0.70est. $1.09 | -35.78%miss | $572.6MSEC filing | +11.1%from $515.3M |
| Dec 31, 2024Reported Feb 6, 2025 | $1.69est. $1.93 | -12.44%miss | $627.7MAlpha Vantage | +21.8%from $515.2M |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $805.5M | $814.5M | $959.0M | $1.12B |
| Cost of what it sold | $17.6M | $13.8M | $23.2M | $26.6M |
| Gross profit | $787.9M | $800.7M | $935.8M | $1.10B |
| What it spent | ||||
| Research and development | $258.2M | $296.2M | $326.7M | $351.8M |
| Sales and admin | $301.8M | $318.5M | $439.7M | $366.3M |
| Other operating costs | $17.0M | — | $16.4M | $46.7M |
| Total operating expenses | $577.0M | $614.7M | $782.8M | $764.8M |
| What was left | ||||
| Operating profit | $210.9M | $186.0M | $153.0M | $331.3M |
| Interest on debt | — | — | $2.9M | $300.0K |
| Profit before tax | $239.4M | $246.8M | $162.2M | $283.7M |
| Tax | $85.7M | $48.9M | $17.8M | $77.2M |
| Net profit | $153.7M | $197.9M | $144.4M | $206.5M |
| EBITDA | $235.4M | $193.3M | $189.9M | $328.0M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Is Ingrezza Quality Of Life Data Altering The Investment Case For Neurocrine Biosciences (NBIX)?
Leans bullishNov 12Form 144 NEUROCRINE BIOSCIENCES For: 10 November By Investing.com
NeutralNov 11Neurocrine Biosciences to Present at the 2026 Jefferies Global Healthcare Conference
NeutralNov 10Is Neurocrine Biosciences (NBIX) Still Cheap As INGREZZA Data And Earnings Outlook Lift Sentiment?
BullishNov 10The Strong Earnings Posted By Neurocrine Biosciences (NASDAQ:NBIX) Are A Good Indication Of The Strength Of The Business
BullishNov 9Adults with uncontrollable movements averaged 5.6 missed work or school days a month before treatment, versus 2.0 after.
NeutralNov 5Neurocrine Biosciences Presents New Tardive Dyskinesia Survey Results Showing Fewer Work and School Disruptions with INGREZZA® (valbenazine) Capsules
BullishNov 5Neurocrine Biosciences, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:NBIX) 2026-11-04
NeutralNov 433 macro signals shaping NBIX right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
